The pathogenic role of IDO1/IDO2 imbalance in COVID-19 and PACS should of course be considered within a wider and more complex scenario where different mechanisms occur, including other metabolic abnormalities involved in immune regulation [254,255,256]. This evidence concerns the gene IDO1 and COVID-19.